tiprankstipranks
Trending News
More News >
Seres Therapeutics (MCRB)
NASDAQ:MCRB

Seres Therapeutics (MCRB) Revenue

Compare
1,065 Followers

Seres Therapeutics Revenue

Seres Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Seres Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
-100.00%
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
103
Market Cap
$63.40M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
0.00-126.33M-100.00%
Dec 31, 2023
126.33M119.20M+1,672.24%
Dec 31, 2022
7.13M-137.80M-95.08%
Dec 31, 2021
144.93M111.71M+336.33%
Dec 31, 2020
33.22M-1.29M-3.74%
Dec 31, 2019
34.51M6.24M+22.07%
Dec 31, 2018
28.27M-3.83M-11.94%
Dec 31, 2017
32.10M10.33M+47.48%
Dec 31, 2016
21.77M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis